AbbVie to Present at the 40th Annual J.P. Morgan Healthcare Conference

<br /> AbbVie to Present at the 40th Annual J.P. Morgan Healthcare Conference<br />

PR Newswire

NORTH CHICAGO, Ill.

,

Jan. 4, 2022

/PRNewswire/ — AbbVie (NYSE: ABBV) will participate in the 40
^th
Annual J.P. Morgan Healthcare Conference on

Tuesday, January 11, 2022

. Members of AbbVie’s executive leadership team will present virtually at

2:45 p.m. CT

, including

Robert A. Michael

, vice chairman, finance and commercial operations and chief financial officer,

Michael E. Severino

, M.D., vice chairman and president, and

Jeffrey R. Stewart

, executive vice president, chief commercial officer.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at

www.abbvie.com

. Follow @abbvie on

Twitter

,

Facebook

,

Instagram

,

YouTube

and

LinkedIn

.